CA3035782A1 - Systemes et procedes pour traiter un il a l'aide d'un flux sanguin retrograde - Google Patents
Systemes et procedes pour traiter un il a l'aide d'un flux sanguin retrograde Download PDFInfo
- Publication number
- CA3035782A1 CA3035782A1 CA3035782A CA3035782A CA3035782A1 CA 3035782 A1 CA3035782 A1 CA 3035782A1 CA 3035782 A CA3035782 A CA 3035782A CA 3035782 A CA3035782 A CA 3035782A CA 3035782 A1 CA3035782 A1 CA 3035782A1
- Authority
- CA
- Canada
- Prior art keywords
- artery
- arterial
- subject
- sheath
- blood flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 85
- 230000017531 blood circulation Effects 0.000 title claims abstract description 76
- 210000001636 ophthalmic artery Anatomy 0.000 claims abstract description 48
- 210000004004 carotid artery internal Anatomy 0.000 claims abstract description 40
- 210000001168 carotid artery common Anatomy 0.000 claims abstract description 23
- 230000001939 inductive effect Effects 0.000 claims abstract description 19
- 210000001367 artery Anatomy 0.000 claims description 62
- 239000008280 blood Substances 0.000 claims description 35
- 210000004369 blood Anatomy 0.000 claims description 35
- 238000003780 insertion Methods 0.000 claims description 11
- 230000037431 insertion Effects 0.000 claims description 11
- 230000001815 facial effect Effects 0.000 claims description 7
- 210000004731 jugular vein Anatomy 0.000 claims description 7
- 238000013459 approach Methods 0.000 claims description 6
- 230000002792 vascular Effects 0.000 claims description 6
- 210000003462 vein Anatomy 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 210000005166 vasculature Anatomy 0.000 description 22
- 230000002441 reversible effect Effects 0.000 description 21
- 208000030533 eye disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 15
- 229910052760 oxygen Inorganic materials 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 235000015097 nutrients Nutrition 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 12
- 230000003073 embolic effect Effects 0.000 description 11
- 239000012530 fluid Substances 0.000 description 11
- 230000002490 cerebral effect Effects 0.000 description 10
- 208000002780 macular degeneration Diseases 0.000 description 10
- 206010064930 age-related macular degeneration Diseases 0.000 description 9
- 238000013152 interventional procedure Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 206010012689 Diabetic retinopathy Diseases 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 210000001715 carotid artery Anatomy 0.000 description 6
- 230000024203 complement activation Effects 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 208000010412 Glaucoma Diseases 0.000 description 5
- 208000006011 Stroke Diseases 0.000 description 5
- 210000003484 anatomy Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000004644 retinal vein occlusion Diseases 0.000 description 4
- 208000005189 Embolism Diseases 0.000 description 3
- 206010016717 Fistula Diseases 0.000 description 3
- 208000001344 Macular Edema Diseases 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 201000007527 Retinal artery occlusion Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000002376 aorta thoracic Anatomy 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000004154 complement system Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000037149 energy metabolism Effects 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000007917 intracranial administration Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000010627 oxidative phosphorylation Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000036262 stenosis Effects 0.000 description 3
- 208000037804 stenosis Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000002177 Cataract Diseases 0.000 description 2
- 206010058202 Cystoid macular oedema Diseases 0.000 description 2
- 238000012276 Endovascular treatment Methods 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010069385 Ocular ischaemic syndrome Diseases 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 206010043189 Telangiectasia Diseases 0.000 description 2
- 210000000702 aorta abdominal Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 201000005845 branch retinal artery occlusion Diseases 0.000 description 2
- 210000000269 carotid artery external Anatomy 0.000 description 2
- 201000005667 central retinal vein occlusion Diseases 0.000 description 2
- 210000001627 cerebral artery Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 201000010206 cystoid macular edema Diseases 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000009056 telangiectasis Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003226 Arteriovenous fistula Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000033379 Chorioretinopathy Diseases 0.000 description 1
- 208000021089 Coats disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010015901 Exudative retinopathy Diseases 0.000 description 1
- 206010065630 Iris neovascularisation Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 206010065534 Macular ischaemia Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 208000009857 Microaneurysm Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 206010036346 Posterior capsule opacification Diseases 0.000 description 1
- 201000004613 Pseudoxanthoma elasticum Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 208000007135 Retinal Neovascularization Diseases 0.000 description 1
- 208000008709 Retinal Telangiectasis Diseases 0.000 description 1
- 208000032437 Retinal deposits Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010038899 Retinal telangiectasia Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 206010038926 Retinopathy hypertensive Diseases 0.000 description 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
- 206010039729 Scotoma Diseases 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000000252 angiomatosis Diseases 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 201000007917 background diabetic retinopathy Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004903 cardiac system Anatomy 0.000 description 1
- 238000013172 carotid endarterectomy Methods 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 201000005849 central retinal artery occlusion Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- -1 complement Chemical compound 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000009556 duplex ultrasonography Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000013171 endarterectomy Methods 0.000 description 1
- 230000019439 energy homeostasis Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000001948 hypertensive retinopathy Diseases 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000006676 mitochondrial damage Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000003142 neovascular glaucoma Diseases 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 1
- 208000023558 pseudoxanthoma elasticum (inherited or acquired) Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004263 retinal angiogenesis Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 201000008979 rubeosis iridis Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3613—Reperfusion, e.g. of the coronary vessels, e.g. retroperfusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12036—Type of occlusion partial occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3655—Arterio-venous shunts or fistulae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0612—Eyes
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgical Instruments (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
La présente invention concerne un procédé d'induction de flux sanguin rétrograde pouvant comprendre l'insertion d'un premier dispositif artériel dans une artère carotide interne et/ou une artère carotide commune d'un sujet. De plus, le procédé peut comprendre l'insertion d'un second dispositif artériel dans une branche terminale d'une artère ophtalmique du sujet. En outre, le procédé peut comprendre l'induction d'un flux sanguin rétrograde dans la première gaine artérielle et la distribution d'au moins une partie du flux sanguin rétrograde induit à travers le second dispositif artériel et dans la branche terminale de l'artère ophtalmique.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662395294P | 2016-09-15 | 2016-09-15 | |
| US62/395,294 | 2016-09-15 | ||
| US201662396091P | 2016-09-16 | 2016-09-16 | |
| US62/396,091 | 2016-09-16 | ||
| PCT/US2017/051551 WO2018053121A1 (fr) | 2016-09-15 | 2017-09-14 | Systèmes et procédés pour traiter un œil à l'aide d'un flux sanguin rétrograde |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3035782A1 true CA3035782A1 (fr) | 2018-03-22 |
Family
ID=59997449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3035782A Abandoned CA3035782A1 (fr) | 2016-09-15 | 2017-09-14 | Systemes et procedes pour traiter un il a l'aide d'un flux sanguin retrograde |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2017325719B2 (fr) |
| CA (1) | CA3035782A1 (fr) |
| WO (1) | WO2018053121A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10342699B2 (en) | 2012-08-03 | 2019-07-09 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
| WO2018140371A1 (fr) | 2017-01-25 | 2018-08-02 | Rmvidlund Llc | Dispositifs d'accès et de fermeture de vaisseau sanguin et procédés d'utilisation associés |
| US10898212B2 (en) | 2017-05-07 | 2021-01-26 | J.D. Franco & Co., Llc | Devices and methods for treating an artery |
| WO2018208622A1 (fr) * | 2017-05-07 | 2018-11-15 | J.D. Franco & Co. | Dispositifs et procédés de traitement d'une artère |
| US10779929B2 (en) | 2017-10-06 | 2020-09-22 | J.D. Franco & Co., Llc | Treating eye diseases by deploying a stent |
| US10758254B2 (en) | 2017-12-15 | 2020-09-01 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
| US11478249B2 (en) | 2018-02-23 | 2022-10-25 | J.D. Franco & Co., Llc | Ophthalmic artery therapy under reverse flow |
| US10695541B1 (en) | 2018-12-31 | 2020-06-30 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3235974A1 (de) * | 1981-11-24 | 1983-06-01 | Volkmar Dipl.-Ing. Merkel (FH), 8520 Erlangen | Vorrichtung zur entfernung bzw. zur aufweitung von engstellen in koerperfluessigkeit fuehrenden gefaessen |
| US6217546B1 (en) * | 1997-05-19 | 2001-04-17 | United States Surgical Corporation | Catheter system |
| US6936060B2 (en) * | 1998-05-13 | 2005-08-30 | Arteria Medical Sciences, Inc. | Apparatus and methods for removing emboli during a surgical procedure |
| WO2003018085A2 (fr) * | 2001-08-22 | 2003-03-06 | Arteria Medical Science, Inc. | Appareil et procedes de traitement d'un accident vasculaire cerebral et de controle des caracteristiques du debit sanguin cerebral |
| US20070213690A1 (en) * | 2006-03-08 | 2007-09-13 | Nickolas Phillips | Blood conduit connector |
-
2017
- 2017-09-14 WO PCT/US2017/051551 patent/WO2018053121A1/fr not_active Ceased
- 2017-09-14 CA CA3035782A patent/CA3035782A1/fr not_active Abandoned
- 2017-09-14 AU AU2017325719A patent/AU2017325719B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017325719A1 (en) | 2019-03-21 |
| WO2018053121A1 (fr) | 2018-03-22 |
| AU2017325719B2 (en) | 2022-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017325719B2 (en) | Systems and methods for treating an eye using retrograde blood flow | |
| US10143585B2 (en) | Systems and methods for treating eye diseases using retrograde blood flow | |
| US10758409B2 (en) | Apparatus and method for treating eye diseases | |
| US12318327B2 (en) | Systems and methods for treating eye diseases | |
| CA2483264C (fr) | Catheter d'infusion presentant une pointe atraumatique | |
| US11690985B2 (en) | Systems and methods for single puncture percutaneous reverse blood flow | |
| US11278389B2 (en) | Methods and devices for treating an eye using a filter | |
| WO2019027380A1 (fr) | Procédé d'injection et dispositif de dilatation pour la pression et la teneur souhaitées d'un liquide et/ou d'un médicament dans la veine avec un cathéter à ballonnet | |
| US10772645B2 (en) | Devices and methods for treating an artery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20231228 |